Placenta
Volume 31, Issue 9 , Pages 770-780 , September 2010

Vascular endothelial growth factor (VEGF) and VEGF-receptor expression in placenta of hyperglycemic pregnant women

  • L. Pietro

      Affiliations

    • Department of Cell and Developmental Biology, Institute of Biomedical Science, University of São Paulo, São Paulo, Brazil
    • Corresponding Author InformationCorresponding author. 229, Leme, SP, 13613-180 Brazil. Tel.: +55 19 3572 1342.
    • ,
  • S. Daher

      Affiliations

    • Department of Obstetrics, Federal University of São Paulo, São Paulo, Brazil
    • ,
  • M.V.C. Rudge

      Affiliations

    • Institute of Gynecology and Obstetrics – São Paulo State University, São Paulo, Brazil
    • ,
  • I.M.P. Calderon

      Affiliations

    • Institute of Gynecology and Obstetrics – São Paulo State University, São Paulo, Brazil
    • ,
  • D.C. Damasceno

      Affiliations

    • Institute of Gynecology and Obstetrics – São Paulo State University, São Paulo, Brazil
    • ,
  • Y.K. Sinzato

      Affiliations

    • Institute of Gynecology and Obstetrics – São Paulo State University, São Paulo, Brazil
    • ,
  • C. Bandeira

      Affiliations

    • Department of Cell and Developmental Biology, Institute of Biomedical Science, University of São Paulo, São Paulo, Brazil
    • ,
  • E. Bevilacqua

      Affiliations

    • Department of Cell and Developmental Biology, Institute of Biomedical Science, University of São Paulo, São Paulo, Brazil

,Accepted 10 July 2010.

References 

  1. Vuorela P. Vascular endothelial growth factor, its receptors, and the Tie receptor in normal and complicated pregnancy. University of Helsinki, Finland. Academic Dissertation; 2000.
  2. Demir R, Kaysli UA, Cayli S, Huppertz B. Sequential steps during vasculogenesis and angiogenesis in the very early human placenta. Placenta. 2006;27:535–539
  3. Demir S, Kayisli UA, Seval Y, Celik-Ozenci C, Korgun ET, Demir-Weusten AY, et al. Sequential expression of VEGF and its receptors in human placental villi during very early pregnancy: differences between placental vasculogenesis and angiogenesis. Placenta. 2004;25:560–572
  4. Breier G. Angiogenesis in embryonic development – a review. Placenta. 2000;21(A):S11–S15
  5. Cooper JC, Sharkey AM, Mclaren J, Charnock-Jones DS, Smith SK. Localization of vascular endothelial growth factor and its receptor, flt, in human placenta and decidua by imunohistochemistry. J Reprod Fertil. 1995;105:205–213
  6. Charnock-Jones DS, Kaufmann P, Mayhew TM. Aspects of human fetoplacental vasculogenesis and angiogenesis. Placenta. 2004;25:103–113
  7. Kingdom J, Huppertz B, Seaward G, Kaufmann P. Development of the placental villous tree and its consequences for fetal growth. Eur J Obstet Gynecol Reprod Biol. 2000;92:35–43
  8. Jirkovska M, Kubinova L, Jancek J, Moravcova M, Krejci V, Karen P. Topological properties and spatial organization of villous capillaries in normal and diabetic placentas. J Vasc Res. 2002;39:268–278
  9. Calderon IMP, Damasceno DC, Amorin RL, Costa RAA, Brasil MAM, Rudge MVC. Morphometric study of placental villi and vessels in women with mild hyperglycemia or gestational or overt diabetes. Diabetes Res Clin Pract. 2007;78:65–71
  10. Rudge MVC, Calderon IMP, Ramos MD, Rodrigues MAM. Diabetes and experimental pregnacy in rats: course of maternal blood glucose levels and its repercussions on the blood glucose levels and pancreas of newborn pups. Braz J Med Biol Res. 1995;28:219–225
  11. Rudge MVC, Gomes CMM, Calderon IMP, Ramos MD, Abbade JF, Oliveira MGM, et al. Study of the evolution of the placenta and fetal pancreas in the pathophysiology of growth retardation intrauterine due to restricted maternal diet. Sao Paulo Med J. 1999;117:49–56
  12. Eriksson J, Hakan Borg LA, Forsberg H, Styrud J. Diabetic embryopathy. Studies with animal and in vitro models. Diabetes. 1991;40(2):94–98
  13. Zhao B, Cai J, Boulton M. Expression of placenta growth factor is regulated by both VEGF and hyperglycemia via VEGFR-2. Microvasc Res. 2004;68:239–246
  14. Kumazaki K, Nakayama M, Suoriyuki N, Wada Y. Expression of vascular endothelial growth factor, placental growth factor and their receptors Flt-1 and KDR in human placenta under pathologic conditions. Hum Pathol. 2002;33:1069–1076
  15. Kerche LTRL, Abbada JF, Costa RAA, Rudge MVC, Calderon IMP. Fetal macrosomia risk in pregnancies complicated by diabetes or daily hyperglycemia. Rev Bras Ginecol Obstet. 2005;27:580–587
  16. Jansson T, Ekstrand Y, Wennwegren M, Powell T. Placental glucose transport in gestational diabetes mellitus. Am J Obstet Gynecol. 2001;184:111–116
  17. Rudge MVC, Calderon IMP, Ramos MD, Brasil MAP, Rugolo LMSS, Bossolan G, et al. Hiperglicemia maternal diária diagnosticada pelo perfil glicêmico: um problema de saúde pública materno perinatal. Rev Bras Ginecol Obstet. 2005;27:691–697
  18. Rudge MVC. Perfil glicêmico e teste de tolerância oral à glicose (GGT) no diagnóstico do diabetes na gestação (Livre-Docência). Botucatu, Faculdade de Medicina de Botucatu, UNESP; 1983;p83
  19. Rudge MVC, Peraçoli JC, Berezowski AT, Calderon IMP, Brasil MAM. The oral glucose tolerance test is a poor predictor of hyperglycemia during the pregnancy2. Braz J Med Biol Res. 1990;23:1079–1089
  20. Americam Diabetes Association Gestational Diabetes Mellitus . Position statements. Diabetes Care. 2004;27(1):S88–S90
  21. Gillmer MDG, Beard RW, Brooke FM, Oakley NW. Carbohydrate metabolism in pregnancy. PartI. Diurnal plasma glucose profile in normal and diabetic women. Br Med J. 1975;16:399–404
  22. Meloan SN, Puchtler H. Demonstration of amyloid with Mesitol WLS-Congo Red: application of a textile auxiliary to histochemistry. Histochemistry. 1978;58:163–166
  23. Junqueira LC, Bignolas G, Brentani RR. Picrosirius staining plus polarization microscopy, a specific method for collagen detection in tissue sections. Hist Jahrb. 1979;11:447–455
  24. Helske S, Vuorella P, Carpen O, Horning C, Weich H, Halmesmaki E. Expression of vascular endothelial growth factor receptors 1, 2 and 3 in placentas from normal and complicated pregnancies. Mol Hum Reprod. 2001;7:205–210
  25. Vuorela P, Halmesmaki E. Vascular endothelial growth factor, its receptors, and the tie receptors in the placental bed of women with preeclampsia, diabetes, and intrauterine growth retardation. Am J Perinatol. 2006;23:255–263
  26. Hadi HA, Suwaidi JA. Endothelial dysfunction in diabetes mellitus. Vasc Health Risk Mang. 2007;3:853–876
  27. Jin SM, Noh CI, Yang SW, Bae EJ, Shin CH, Chung HR, et al. Endothelial dysfunction and microvascular complications in type 1 diabetes mellitus. J Korean Med Sci. 2008;23:77–82
  28. Klip A, Marette A, Dimitrakoudis D, Ramlat T, Giacca A, Shi ZQ, et al. Effect of diabetes on glucoregulation. From glucose transporters to glucose metabolism in vivo. Diabetes Care. 1992;15:1747–1766
  29. Taskinen MR. Criteria for metabolic control and intervention in diabetes. Diabetes. 1996;45(3):S120–S122
  30. Vlassara H, Brownlee M, Cerami A. Accumulation of diabetic rat peripheral nerve myelin by macrophages increases with the presence of advanced glycosylation endproducts. J Exp Med. 1984;160:197–207
  31. Browlee M. Biochemistry and molecular cell biology of diabetic complications. Nature. 2001;13:813–820
  32. Hull RL, Westermark GT, Westermark P, Kahn SE. Islet amyloid: a critical entity in the pathogenesis of type 2 diabetes. J Clin Endocrinol Metab. 2004;89:3629–3643
  33. Butler AE, Jang J, Gurlo T, Carty MD, Soeller WC, Bulter PC. Diabetes due to a progressive defect in beta-cell mass in rats transgenic for human islet amyloid polypeptide (HIP Rat): a new model for type 2 diabetes. Diabetes. 2004;53:1509–1516
  34. Esper RJ, Vilariño JO, Machado RA, Paragano A. Endothelial dysfunction in normal and abnormal glucose metabolism. Adv Cardiol. 2008;45:17–43
  35. Li Q, Wu SH, Pan JM, Tang JL, Zhang Y, Lu HJ, et al. Glycated albumin level and its influential factors in type 2 diabetes mellitus. Zhonghua Yi Xue Za Zhi. 2007;87:2994–2996
  36. Vranes D, Cooper ME, Dilley RJ. Cellular mechanisms of diabetic vascular hypertrophy. Microvasc Res. 1999;57:8–18
  37. Iino K, Yoshinari M, Doi Y, Shinohara N, Iwase M, Fujishima M. Reduced tissue oxygenation and its reversibility by glycemic control in diabetic patients. Diabetes Res Clin Pract. 1997;34:163–168
  38. Watala C, Golaski J, Witas H, Gurbiel R, Gwoidzifiski K, Trojanowski Z. The effects of in vivo and in vitro non-enzymatic glycosylation and glycoxidation on physico-chemical properties of haemoglobin in control and diabetic patients. Int J Biochem Cell Biol. 1996;28:1343–1403
  39. Ferrara N, Gerber HP, Lecouter J. The biology of VEGF and its receptors. Nat Med. 2003;9:669–676
  40. Liekens S, Clercq ED, Neyts J. Angiogenesis: regulators and clinical applications. Biochem Pharmacol. 2001;61:253–270
  41. Hicklin D, Ellis LM. Role of the vascular endothelial growth factor pathway in tumor growth and angiogenesis. J Clin Oncol. 2005;23:1011–1027
  42. Kanno S, Oda N, Abe M, Terai Y, Ito M, Shitara K, et al. Roles of two VEGF receptors, Flt-1 and KDR, in the signal transduction of VEGF effects in human vascular endothelial cells. Oncogene. 2000;19:2138–2146
  43. Takashi H, Shibuya M. The vascular endothelial growth factor (VEGF)/VEGF receptor system and its role under physiological and pathological conditions. Clin Sci. 2005;109:227–241
  44. Shibuya M, Claesson-Welsh L. Signal transduction by VEGF receptors in regulation of angiogenesis and lymphagiesis. Exp Cell Res. 2006;312:549–560
  45. Carmeliet P, Moons L, Lutun A. Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and extravasation in pathological coditions. Nat Med. 2001;7:575–583

☆ Grant support: This research was supported by Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP), Coordenadoria de Aperfeiçoamento de Pessoal de Nível Superior (CAPES) and Conselho Nacional de Pesquisa e Desenvolvimento Tecnológico (CNPq).

PII: S0143-4004(10)00263-8

doi: 10.1016/j.placenta.2010.07.003

Placenta
Volume 31, Issue 9 , Pages 770-780 , September 2010

Article Tools

* Image Usage & Resolution